First Trust Advisors’s Intellia Therapeutics NTLA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $95.9K | Buy |
+10,228
| New | +$95.9K | ﹤0.01% | 2571 |
|
2024
Q2 | – | Sell |
-51,438
| Closed | -$1.42M | – | 2395 |
|
2024
Q1 | $1.42M | Buy |
+51,438
| New | +$1.42M | ﹤0.01% | 1870 |
|
2023
Q4 | – | Sell |
-33,208
| Closed | -$1.05M | – | 2403 |
|
2023
Q3 | $1.05M | Buy |
+33,208
| New | +$1.05M | ﹤0.01% | 1947 |
|
2022
Q1 | – | Sell |
-71,282
| Closed | -$8.43M | – | 2572 |
|
2021
Q4 | $8.43M | Buy |
71,282
+5,826
| +9% | +$689K | 0.01% | 1124 |
|
2021
Q3 | $8.78M | Sell |
65,456
-4,895
| -7% | -$657K | 0.01% | 1044 |
|
2021
Q2 | $11.4M | Sell |
70,351
-24,946
| -26% | -$4.04M | 0.01% | 962 |
|
2021
Q1 | $7.65M | Buy |
95,297
+25,283
| +36% | +$2.03M | 0.01% | 1035 |
|
2020
Q4 | $3.81M | Buy |
+70,014
| New | +$3.81M | 0.01% | 1233 |
|
2019
Q1 | – | Sell |
-67,322
| Closed | -$919K | – | 2441 |
|
2018
Q4 | $919K | Sell |
67,322
-92,981
| -58% | -$1.27M | ﹤0.01% | 1864 |
|
2018
Q3 | $4.59M | Buy |
160,303
+55,798
| +53% | +$1.6M | 0.01% | 1193 |
|
2018
Q2 | $2.86M | Buy |
+104,505
| New | +$2.86M | 0.01% | 1412 |
|